Vascular Injury

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS approval · 2025-08-24
Clinical Trial Update: Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System Injuries
Humacyte's Acellular Tissue Engineered Vessel (ATEV) has been approved for marketing for vascular injuries, with an update noting expanded a…